$USPH
U S PHYSICAL THERAPY INC /NV

2021 Form 10-K Financial Statement

#000114036122007247 Filed on March 01, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $495.0M $117.5M $423.0M
YoY Change 17.04% -3.78% -12.24%
Cost Of Revenue $377.8M $88.30M $324.6M
YoY Change 16.39% -7.15% -12.15%
Gross Profit $117.2M $29.10M $94.45M
YoY Change 24.07% 7.94% -16.03%
Gross Profit Margin 23.67% 24.77% 22.33%
Selling, General & Admin $46.53M $10.90M $42.04M
YoY Change 10.7% -6.84% -6.69%
% of Gross Profit 39.71% 37.46% 44.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.59M $2.460M $10.53M
YoY Change 10.04% -9.56% 4.34%
% of Gross Profit 9.89% 8.45% 11.15%
Operating Expenses $46.53M $10.90M $42.04M
YoY Change 10.7% -6.84% -6.69%
Operating Profit $70.65M $18.20M $52.41M
YoY Change 34.79% 19.06% -22.26%
Interest Expense -$631.0K -$200.0K -$400.0K
YoY Change 57.75% -75.0% -119.24%
% of Operating Profit -0.89% -1.1% -0.76%
Other Income/Expense, Net $2.547M $13.10M
YoY Change -80.56% 276.33%
Pretax Income $73.20M $23.20M $65.51M
YoY Change 11.73% 61.11% -7.61%
Income Tax $15.27M $4.600M $13.02M
% Of Pretax Income 20.86% 19.83% 19.88%
Net Earnings $40.83M $13.00M $35.19M
YoY Change 16.02% 64.56% -12.1%
Net Earnings / Revenue 8.25% 11.06% 8.32%
Basic Earnings Per Share $2.41 $2.48
Diluted Earnings Per Share $2.41 $1.008M $2.48
COMMON SHARES
Basic Shares Outstanding 12.90M 12.84M
Diluted Shares Outstanding 12.90M 12.84M

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.57M $32.90M $32.90M
YoY Change -13.17% 40.0% 40.0%
Cash & Equivalents $28.57M $32.92M $32.90M
Short-Term Investments
Other Short-Term Assets $3.583M $3.773M $3.100M
YoY Change 15.58% -34.8% -27.91%
Inventory
Prepaid Expenses
Receivables $62.42M $41.91M $50.90M
Other Receivables $600.0K $0.00 $700.0K
Total Short-Term Assets $95.17M $87.64M $87.60M
YoY Change 8.64% 2.64% 2.58%
LONG-TERM ASSETS
Property, Plant & Equipment $119.4M $21.67M $103.3M
YoY Change 15.59% -1.92% -0.39%
Goodwill $345.6M
YoY Change 8.8%
Intangibles $56.28M
YoY Change 7.02%
Long-Term Investments $12.22M
YoY Change
Other Assets $1.578M $1.539M $1.500M
YoY Change 5.2% 1.32% 0.0%
Total Long-Term Assets $654.3M $506.7M $506.8M
YoY Change 29.1% -7.04% 6.6%
TOTAL ASSETS
Total Short-Term Assets $95.17M $87.64M $87.60M
Total Long-Term Assets $654.3M $506.7M $506.8M
Total Assets $749.4M $594.4M $594.4M
YoY Change 26.08% -5.73% 5.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.471M $1.300M $1.300M
YoY Change 397.77% -48.0% -48.0%
Accrued Expenses $73.46M $59.75M $81.50M
YoY Change -9.86% 93.63% 42.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $830.0K $4.899M $4.900M
YoY Change -83.06% 572.94% 600.0%
Total Short-Term Liabilities $83.48M $93.49M $93.50M
YoY Change -10.72% 54.37% 54.29%
LONG-TERM LIABILITIES
Long-Term Debt $117.6M $16.60M $16.60M
YoY Change 608.36% -67.05% -67.06%
Other Long-Term Liabilities $81.53M $4.539M $66.50M
YoY Change 22.6% 3119.15% 10.1%
Total Long-Term Liabilities $199.1M $21.14M $83.10M
YoY Change 139.61% -58.15% -25.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $83.48M $93.49M $93.50M
Total Long-Term Liabilities $199.1M $21.14M $83.10M
Total Liabilities $453.8M $184.4M $318.2M
YoY Change 42.62% 1.65% -0.75%
SHAREHOLDERS EQUITY
Retained Earnings $212.0M
YoY Change 15.01%
Common Stock $151.0K
YoY Change 0.67%
Preferred Stock
YoY Change
Treasury Stock (at cost) $31.63M
YoY Change 0.0%
Treasury Stock Shares $2.215M
Shareholders Equity $295.6M $276.2M $276.2M
YoY Change
Total Liabilities & Shareholders Equity $749.4M $594.4M $594.4M
YoY Change 26.08% 5.98% 5.99%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income $40.83M $13.00M $35.19M
YoY Change 16.02% 64.56% -12.1%
Depreciation, Depletion And Amortization $11.59M $2.460M $10.53M
YoY Change 10.04% -9.56% 4.34%
Cash From Operating Activities $76.41M $25.40M $100.0M
YoY Change -23.59% 58.85% 60.13%
INVESTING ACTIVITIES
Capital Expenditures -$8.201M -$2.150M -$7.640M
YoY Change 7.34% -22.1% -25.02%
Acquisitions $86.82M $23.91M
YoY Change 263.17% -21.86%
Other Investing Activities -$115.9M -$26.14M -$43.56M
YoY Change 166.15% 701.84% 56.69%
Cash From Investing Activities -$124.1M -$28.28M -$51.20M
YoY Change 142.44% 369.77% 34.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00 $0.00
YoY Change
Cash From Financing Activities 43.38M 5.690M -39.42M
YoY Change -210.04% -139.87% 62.4%
NET CHANGE
Cash From Operating Activities 76.41M 25.40M 100.0M
Cash From Investing Activities -124.1M -28.28M -51.20M
Cash From Financing Activities 43.38M 5.690M -39.42M
Net Change In Cash -4.351M 2.810M 9.370M
YoY Change -146.44% -165.35% 5105.56%
FREE CASH FLOW
Cash From Operating Activities $76.41M $25.40M $100.0M
Capital Expenditures -$8.201M -$2.150M -$7.640M
Free Cash Flow $84.61M $27.55M $107.6M
YoY Change -21.39% 46.93% 48.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2700000
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Registrant Name
EntityRegistrantName
U S PHYSICAL THERAPY INC /NV
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0000885978
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021 dei Auditor Firm
AuditorFirmId
248
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
1-11151
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0364866
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1300 WEST SAM HOUSTON PARKWAY SOUTH
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 300
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
HOUSTON
CY2021 dei Local Phone Number
LocalPhoneNumber
297-7000
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $.01 par value
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77042
CY2021 dei City Area Code
CityAreaCode
713
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Trading Symbol
TradingSymbol
USPH
CY2021 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
838000000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12950588
CY2021 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2021 dei Auditor Location
AuditorLocation
Houston, Texas
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28567000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32918000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2768000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2008000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46272000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41906000
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
16144000
CY2020Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
9039000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4183000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3773000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
95166000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
87636000
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
58743000
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
55426000
CY2021Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
39194000
CY2020Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
35320000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
97937000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
90746000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
74958000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
69081000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22979000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21665000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
96427000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
81595000
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
12215000
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0
CY2021Q4 us-gaap Goodwill
Goodwill
434679000
CY2020Q4 us-gaap Goodwill
Goodwill
345646000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
86382000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
56280000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1578000
CY2021Q4 usph Accounts Payable Due To Seller Of Acquired Business
AccountsPayableDueToSellerOfAcquiredBusiness
3203000
CY2020Q4 usph Accounts Payable Due To Seller Of Acquired Business
AccountsPayableDueToSellerOfAcquiredBusiness
0
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1539000
CY2021Q4 us-gaap Assets
Assets
749426000
CY2020Q4 us-gaap Assets
Assets
594361000
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3268000
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1335000
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
114000000
CY2020Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
16000000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
83481000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45705000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59746000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
30475000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
27512000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
830000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4899000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
93492000
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
3587000
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
596000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
14385000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7779000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74185000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
61985000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7345000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4539000
CY2021Q4 us-gaap Liabilities
Liabilities
296983000
CY2020Q4 us-gaap Liabilities
Liabilities
184391000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
155262000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
132340000
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15126160
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15066282
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
151000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
151000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102688000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
95622000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
224395000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
212015000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2214737
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2214737
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
295606000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
276160000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
1575000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
1470000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
297181000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
277630000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
749426000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
594361000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
495022000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
422969000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
481969000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
278469000
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
235629000
CY2019 us-gaap Labor And Related Expense
LaborAndRelatedExpense
274233000
CY2021 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
94036000
CY2020 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
84336000
CY2019 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
90379000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5305000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4623000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4858000
CY2021 us-gaap Restructuring Charges
RestructuringCharges
30000
CY2020 us-gaap Restructuring Charges
RestructuringCharges
2072000
CY2019 us-gaap Restructuring Charges
RestructuringCharges
25000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1859000
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
377840000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
328519000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
369495000
CY2021 us-gaap Gross Profit
GrossProfit
117182000
CY2020 us-gaap Gross Profit
GrossProfit
94450000
CY2019 us-gaap Gross Profit
GrossProfit
112474000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46533000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42037000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
45049000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
70649000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
52413000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
67425000
CY2021 usph Relief Funds
ReliefFunds
4597000
CY2020 usph Relief Funds
ReliefFunds
13501000
CY2019 usph Relief Funds
ReliefFunds
0
CY2021 us-gaap Gain Loss On Sale Of Interest In Projects
GainLossOnSaleOfInterestInProjects
0
CY2020 us-gaap Gain Loss On Sale Of Interest In Projects
GainLossOnSaleOfInterestInProjects
1091000
CY2019 us-gaap Gain Loss On Sale Of Interest In Projects
GainLossOnSaleOfInterestInProjects
5514000
CY2021 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
2635000
CY2020 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0
CY2019 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0
CY2021 usph Resolution Of Payor Matter
ResolutionOfPayorMatter
1216000
CY2020 usph Resolution Of Payor Matter
ResolutionOfPayorMatter
0
CY2019 usph Resolution Of Payor Matter
ResolutionOfPayorMatter
0
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
112000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
199000
CY2020 us-gaap Interest And Other Income
InterestAndOtherIncome
142000
CY2019 us-gaap Interest And Other Income
InterestAndOtherIncome
46000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65513000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
70906000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15272000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13022000
CY2021 usph Interest Expense Debt And Other
InterestExpenseDebtAndOther
942000
CY2020 usph Interest Expense Debt And Other
InterestExpenseDebtAndOther
1634000
CY2019 usph Interest Expense Debt And Other
InterestExpenseDebtAndOther
2079000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2547000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13100000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3481000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73196000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13647000
CY2021 us-gaap Profit Loss
ProfitLoss
57924000
CY2020 us-gaap Profit Loss
ProfitLoss
52491000
CY2019 us-gaap Profit Loss
ProfitLoss
57259000
CY2021 usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
11358000
CY2020 usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
11175000
CY2019 usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
10659000
CY2021 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
5735000
CY2020 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
6122000
CY2019 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
6561000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17093000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17297000
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17220000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
40831000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
35194000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
40039000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
2.41
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
2.48
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
2.45
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12898000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12835000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12756000
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.46
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.32
CY2019 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.14
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
216875000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2019 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-8771000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6985000
CY2019 usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
636000
CY2019 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
292000
CY2019 usph Sale Of Non Controlling Interest Net Of Tax And Purchases
SaleOfNonControllingInterestNetOfTaxAndPurchases
196000
CY2019 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
14555000
CY2019 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
6014000
CY2019 us-gaap Stockholders Equity Other
StockholdersEquityOther
40000
CY2019 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
6561000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
40039000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
241701000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2020 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-3415000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7917000
CY2020 usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
486000
CY2020 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
168000
CY2020 usph Sale Of Non Controlling Interest Net Of Tax And Purchases
SaleOfNonControllingInterestNetOfTaxAndPurchases
-164000
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4110000
CY2020 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5928000
CY2020 us-gaap Stockholders Equity Other
StockholdersEquityOther
-6000
CY2020 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
6122000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
35194000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
277630000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2021 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-9686000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7867000
CY2021 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
978000
CY2021 usph Sale Of Non Controlling Interest Net Of Tax And Purchases
SaleOfNonControllingInterestNetOfTaxAndPurchases
98000
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
18765000
CY2021 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5572000
CY2021 usph Short Swing Profit Settlement
ShortSwingProfitSettlement
20000
CY2021 us-gaap Stockholders Equity Other
StockholdersEquityOther
1000
CY2021 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
5735000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
40831000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
297181000
CY2021 us-gaap Profit Loss
ProfitLoss
57924000
CY2020 us-gaap Profit Loss
ProfitLoss
52491000
CY2019 us-gaap Profit Loss
ProfitLoss
57259000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11591000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10533000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10095000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5305000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4623000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4858000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7867000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
7917000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
6985000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5688000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-258000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4651000
CY2021 usph Gain On Sale Of Partnership Interest Net Of Tax
GainOnSaleOfPartnershipInterestNetOfTax
0
CY2020 usph Gain On Sale Of Partnership Interest Net Of Tax
GainOnSaleOfPartnershipInterestNetOfTax
1091000
CY2019 usph Gain On Sale Of Partnership Interest Net Of Tax
GainOnSaleOfPartnershipInterestNetOfTax
5514000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
16235000
CY2019 usph Distributions From Unconsolidated Affiliate
DistributionsFromUnconsolidatedAffiliate
0
CY2021 usph Proceeds From Sales Of Non Controlling Interest Permanent
ProceedsFromSalesOfNonControllingInterestPermanent
131000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1859000
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
112000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2021 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-134000
CY2020 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
281000
CY2019 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
96000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9417000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-899000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6376000
CY2021 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
1538000
CY2020 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-1661000
CY2019 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
2499000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
633000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4161000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1878000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4657000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12427000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4209000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-4792000
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
4492000
CY2019 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1020000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76406000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
99995000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62448000
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8201000
CY2020 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7639000
CY2019 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
10189000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
86823000
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
23907000
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
30597000
CY2021 usph Payments To Acquire Redeemable Non Controlling Interest
PaymentsToAcquireRedeemableNonControllingInterest
28465000
CY2020 usph Payments To Acquire Redeemable Non Controlling Interest
PaymentsToAcquireRedeemableNonControllingInterest
20385000
CY2019 usph Payments To Acquire Redeemable Non Controlling Interest
PaymentsToAcquireRedeemableNonControllingInterest
8651000
CY2021 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
1274000
CY2020 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
238000
CY2019 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
428000
CY2021 us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
69000
CY2020 us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
127000
CY2019 us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
207000
CY2021 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
275000
CY2020 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
839000
CY2019 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
11665000
CY2021 usph Distributions From Unconsolidated Affiliate
DistributionsFromUnconsolidatedAffiliate
152000
CY2020 usph Distributions From Unconsolidated Affiliate
DistributionsFromUnconsolidatedAffiliate
0
CY2020 usph Proceeds From Sales Of Non Controlling Interest Permanent
ProceedsFromSalesOfNonControllingInterestPermanent
0
CY2019 usph Proceeds From Sales Of Non Controlling Interest Permanent
ProceedsFromSalesOfNonControllingInterestPermanent
0
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-124136000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51203000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37993000
CY2021 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
16931000
CY2020 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
18331000
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18765000
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4110000
CY2019 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
14555000
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
316000000
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
214000000
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
145000000
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
218000000
CY2020 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
244000000
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
137000000
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4899000
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1037000
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1433000
CY2021 usph Medicare Accelerated And Advance Payment Funds
MedicareAcceleratedAndAdvancePaymentFunds
-14054000
CY2020 usph Medicare Accelerated And Advance Payment Funds
MedicareAcceleratedAndAdvancePaymentFunds
14054000
CY2019 usph Medicare Accelerated And Advance Payment Funds
MedicareAcceleratedAndAdvancePaymentFunds
0
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
28000
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2000
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-52000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
43379000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-39422000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24275000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4351000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9370000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
180000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32918000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23548000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23368000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28567000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32918000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23548000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12214000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7677000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9856000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1352000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1202000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
1890000
CY2021 usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
3050000
CY2020 usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
1121000
CY2019 usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
4300000
CY2021 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0
CY2020 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0
CY2019 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
502000
CY2021Q4 usph Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity
NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
1759000
CY2020Q4 usph Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity
NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
136000
CY2019Q4 usph Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity
NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
283000
CY2021Q4 usph Notes Payable Related To Purchase Of Non Controlling Interest Permanent Equity
NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
0
CY2020Q4 usph Notes Payable Related To Purchase Of Non Controlling Interest Permanent Equity
NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
699000
CY2019Q4 usph Notes Payable Related To Purchase Of Non Controlling Interest Permanent Equity
NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
103000
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
914000
CY2020 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0
CY2019 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
2870000
CY2021 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0
CY2020 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
994000
CY2019 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021 usph Percentage Of General Partnership Interest Owned
PercentageOfGeneralPartnershipInterestOwned
0.01
CY2021 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
5
CY2020 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
3
CY2021Q4 usph Number Of Closed Clinics Sold
NumberOfClosedClinicsSold
2
CY2021 usph Aggregate Sale Price Of Cinics
AggregateSalePriceOfCinics
100000
CY2020Q4 usph Number Of Closed Clinics Sold
NumberOfClosedClinicsSold
14
CY2020 usph Aggregate Sale Price Of Cinics
AggregateSalePriceOfCinics
1100000
CY2020Q4 usph Cash Received Related To Sale Of Clinics
CashReceivedRelatedToSaleOfClinics
700000
CY2020Q4 usph Note Receivable Related To Sale Of Clinics
NoteReceivableRelatedToSaleOfClinics
400000
CY2020 usph Number Of Installments For Note Receivable In Sale Consideration
NumberOfInstallmentsForNoteReceivableInSaleConsideration
2
CY2021 usph Number Of Regions
NumberOfRegions
6
CY2019 usph Number Of Regions
NumberOfRegions
6
CY2020 usph Number Of Regions
NumberOfRegions
6
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2020 usph Number Of Regions
NumberOfRegions
6
CY2019 usph Number Of Regions
NumberOfRegions
6
CY2021 usph Number Of Regions
NumberOfRegions
6
CY2021 usph Percentage Of Payment For Outpatient Therapy Services
PercentageOfPaymentForOutpatientTherapyServices
0.85
CY2021Q2 usph Percentage Of Payment Reduction Waived Through Enacted Legislation
PercentageOfPaymentReductionWaivedThroughEnactedLegislation
0.02
CY2021 usph Period Of Extension
PeriodOfExtension
P3M
CY2021Q2 usph Percentage Of Payment Reduction Waived Through Enacted Legislation
PercentageOfPaymentReductionWaivedThroughEnactedLegislation
0.02
CY2021 usph Net Revenue From Medicare
NetRevenueFromMedicare
134400000
CY2020 usph Net Revenue From Medicare
NetRevenueFromMedicare
101600000
CY2021 usph Percentage Of Payment Reduction Waived Through Enacted Legislation Period Two
PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo
0.01
CY2021 usph Percentage Of Increase In Payment Adjustment For Therapists Participating In Merit Based Incentive Payment System
PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem
0.01
CY2021 usph Combined Physical Therapy Speech Language Pathology Expenses
CombinedPhysicalTherapySpeechLanguagePathologyExpenses
3700
CY2021 usph Combined Physical Therapy Speech Language Pathology Expenses
CombinedPhysicalTherapySpeechLanguagePathologyExpenses
3700
CY2021 usph Combined Physical Therapy Speech Language Pathology Expenses
CombinedPhysicalTherapySpeechLanguagePathologyExpenses
3700
CY2021 usph Combined Physical Therapy Speech Language Pathology Expenses
CombinedPhysicalTherapySpeechLanguagePathologyExpenses
3700
CY2021 usph Reduction In Combined Physical Therapy Speech Language Pathology Expenses
ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses
3000
CY2021 usph Percentage Of Practice Expense Component Of Relative Value Unit
PercentageOfPracticeExpenseComponentOfRelativeValueUnit
1
CY2021 usph Percentage Reduction For Service In Office Or Other Non Institutional Settings
PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings
0.50
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
495022000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
422969000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
481969000
CY2021 usph Estimated Percentage Of Decrease In Payment
EstimatedPercentageOfDecreaseInPayment
0.035
CY2021 usph Period Of Federal Debt Ceiling In Connection With Deficit Reductions
PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions
P10Y
CY2021 usph Amount Of Reductions In Federal Spending
AmountOfReductionsInFederalSpending
1200000000000
CY2021 usph Reduction In Medicare Spending Percentage
ReductionInMedicareSpendingPercentage
0.02
CY2013Q2 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02
CY2015Q4 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02
CY2018Q1 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02
CY2021Q4 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02
CY2021Q4 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02
CY2021 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2020Q4 usph Patients And Payors Related Liability
PatientsAndPayorsRelatedLiability
5756000
CY2021Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1984000
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2020 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q4 usph Patients And Payors Related Liability
PatientsAndPayorsRelatedLiability
6649000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3414000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3015000
CY2020Q4 us-gaap Goodwill
Goodwill
345646000
CY2019Q4 us-gaap Goodwill
Goodwill
317676000
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
89746000
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
28540000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1859000
CY2021 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-713000
CY2020 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
1289000
CY2021Q4 us-gaap Goodwill
Goodwill
434679000
CY2020Q4 us-gaap Goodwill
Goodwill
345646000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1900000
CY2020Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
2113000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
86382000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
56280000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3698000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23569000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24646000
CY2021 usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
5
CY2021 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
1300000
CY2021 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
100000
CY2020 usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
5
CY2020 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
300000
CY2020 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
100000
CY2020Q4 usph Number Of Closed Clinics Sold
NumberOfClosedClinicsSold
14
CY2020 usph Aggregate Sale Price Of Cinics
AggregateSalePriceOfCinics
1100000
CY2020Q4 usph Cash Received Related To Sale Of Clinics
CashReceivedRelatedToSaleOfClinics
700000
CY2020Q4 usph Note Receivable Related To Sale Of Clinics
NoteReceivableRelatedToSaleOfClinics
400000
CY2020 usph Number Of Installments For Note Receivable In Sale Consideration
NumberOfInstallmentsForNoteReceivableInSaleConsideration
2
CY2019 usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
4
CY2019 usph Sale Of Noncontrolling Interest Percentage In Partnership One
SaleOfNoncontrollingInterestPercentageInPartnershipOne
0.01
CY2019 usph Tax Effect On Sale Of Noncontrolling Interest
TaxEffectOnSaleOfNoncontrollingInterest
196000
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
498000
CY2020Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1333000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2716000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
9885000
CY2021Q4 usph Medicare Accelerated And Advance Payments Program Funds Payable
MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable
0
CY2020Q4 usph Medicare Accelerated And Advance Payments Program Funds Payable
MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable
14054000
CY2021Q4 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
1000000
CY2020Q4 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
0
CY2021Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
2750000
CY2020Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6539000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1959000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45705000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59746000
CY2021Q4 usph Deferred Employer Payroll Taxes Caresact
DeferredEmployerPayrollTaxesCARESACT
4200000
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1500000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
118417000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
21495000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
830000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4899000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
117587000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16596000
CY2021 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.003
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
32021000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
30710000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1160000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1454000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
7057000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
5752000
CY2021 us-gaap Lease Cost
LeaseCost
40238000
CY2020 us-gaap Lease Cost
LeaseCost
37916000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
33192000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
30307000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
46088000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
32710000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
32945000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
27467000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
20876000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
14000000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
8492000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
7055000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
110835000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6175000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
104660000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M1D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y18D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0277
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.031
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2817000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1865000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
573000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
396000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
558000
CY2021Q4 usph Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
26856000
CY2020Q4 usph Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
23819000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30246000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
26638000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
19607000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
12650000
CY2021Q4 usph Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
24637000
CY2020Q4 usph Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
21419000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
387000
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
348000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
44631000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
34417000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
14385000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7779000
CY2021Q4 usph Deferred Tax Assets Related To Redeemable Non Controlling Interests And Acquisitions Of Non Controlling Interests
DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests
800000
CY2021 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
3000000.0
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
11782000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
10125000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
11274000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2478000
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.044
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1956000
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.039
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2059000
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.038
CY2021 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
246000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.004
CY2020 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
99000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
-0
CY2019 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
871000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.016
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1258000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.022
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1040000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.021
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1185000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.022
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15272000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.272
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13022000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.270
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13647000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.254
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
7477000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
10506000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6523000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2107000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2774000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2473000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
9584000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
13280000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8996000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
4866000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-38000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3730000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
822000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-220000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
921000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5688000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-258000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4651000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15272000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13022000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13647000
CY2021 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021 us-gaap Revenues
Revenues
495022000
CY2020 us-gaap Revenues
Revenues
422969000
CY2019 us-gaap Revenues
Revenues
481969000
CY2021 us-gaap Gross Profit
GrossProfit
117182000
CY2020 us-gaap Gross Profit
GrossProfit
94450000
CY2019 us-gaap Gross Profit
GrossProfit
112474000
CY2021Q4 us-gaap Assets
Assets
749426000
CY2020Q4 us-gaap Assets
Assets
594361000
CY2019Q4 us-gaap Assets
Assets
630501000
CY2021Q4 usph Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Grants For The Cumulative Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod
1583257
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2021Q4 usph Share Based Compensation Arrangement By Share Based Payment Award Options Exercises For The Cumulative Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod
918091
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
172657
CY2021Q4 usph Share Based Compensation Arrangement By Share Based Payment Award For Shares Outstanding Restrictions Had Not Lapsed
ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed
102682
CY2020Q4 usph Share Based Compensation Arrangement By Share Based Payment Award For Shares Outstanding Restrictions Had Not Lapsed
ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed
127562
CY2009Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
859499
CY2021 usph Additional Estimated Repurchase Of Common Stock
AdditionalEstimatedRepurchaseOfCommonStock
156986
CY2021Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
95.55
CY2020 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2021 usph Employment Agreements Expiration Date
EmploymentAgreementsExpirationDate
2022-11-08
CY2020 us-gaap Net Income Loss
NetIncomeLoss
35194000
CY2021 usph Defined Contribution Plan Period For New Employees Covered Under Plan
DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan
P3M
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2021 usph Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
1900000
CY2020 usph Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
1900000
CY2019 usph Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
2000000.0
CY2021 usph Employment Agreements Expiration Date Two
EmploymentAgreementsExpirationDateTwo
2023-07-01
CY2021 usph Employment Agreements Expiration Date Three
EmploymentAgreementsExpirationDateThree
2023-12-31
CY2021 usph Employment Agreements Expiration Date Four
EmploymentAgreementsExpirationDateFour
2024-02-28
CY2021 usph Renewal Period For Employment Agreement
RenewalPeriodForEmploymentAgreement
P2Y
CY2021Q4 usph Employee Compensation Future Payment Due Next Fiscal Year
EmployeeCompensationFuturePaymentDueNextFiscalYear
52800000
CY2021Q4 usph Employee Compensation Future Payment Due Next Fiscal Year Thereafter
EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter
8400000
CY2019Q4 us-gaap Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
3
CY2021 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
2600000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
40831000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
40039000
CY2021 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-13011000
CY2020 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-4632000
CY2019 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-11893000
CY2021 usph Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate
0.2555
CY2020 usph Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate
0.2625
CY2021 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-3324000
CY2020 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-1216000
CY2019 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-3121000
CY2021 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
31144000
CY2020 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
31778000
CY2019 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
31267000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.41
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.41
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.48
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.48
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.45
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.45
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12898000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12898000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12835000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12835000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12756000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12756000
CY2021 usph Short Swing Profit Settlement
ShortSwingProfitSettlement
20000

Files In Submission

Name View Source Status
0001140361-22-007247-index-headers.html Edgar Link pending
0001140361-22-007247-index.html Edgar Link pending
0001140361-22-007247.txt Edgar Link pending
0001140361-22-007247-xbrl.zip Edgar Link pending
brhc10034321_10k.htm Edgar Link pending
brhc10034321_10k_htm.xml Edgar Link completed
brhc10034321_ex10-54.htm Edgar Link pending
brhc10034321_ex21-1.htm Edgar Link pending
brhc10034321_ex23-1.htm Edgar Link pending
brhc10034321_ex31-1.htm Edgar Link pending
brhc10034321_ex31-2.htm Edgar Link pending
brhc10034321_ex31-3.htm Edgar Link pending
brhc10034321_ex32-1.htm Edgar Link pending
brhc10034321_ex4-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image00002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usph-20211231.xsd Edgar Link pending
usph-20211231_cal.xml Edgar Link unprocessable
usph-20211231_def.xml Edgar Link unprocessable
usph-20211231_lab.xml Edgar Link unprocessable
usph-20211231_pre.xml Edgar Link unprocessable